VALENTINI, GIOVANNA
 Distribuzione geografica
Continente #
NA - Nord America 2.145
EU - Europa 1.680
AS - Asia 1.050
AF - Africa 6
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.887
Nazione #
US - Stati Uniti d'America 2.134
CN - Cina 1.029
IE - Irlanda 519
UA - Ucraina 328
FI - Finlandia 255
DE - Germania 163
SE - Svezia 135
IT - Italia 105
GB - Regno Unito 79
FR - Francia 44
BE - Belgio 27
CA - Canada 11
NL - Olanda 8
IN - India 7
IR - Iran 5
CZ - Repubblica Ceca 4
MU - Mauritius 4
RU - Federazione Russa 3
AR - Argentina 2
AT - Austria 2
CL - Cile 2
EG - Egitto 2
HK - Hong Kong 2
MD - Moldavia 2
PK - Pakistan 2
RO - Romania 2
AU - Australia 1
CH - Svizzera 1
ES - Italia 1
EU - Europa 1
GR - Grecia 1
IQ - Iraq 1
JO - Giordania 1
JP - Giappone 1
LV - Lettonia 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 4.887
Città #
Dublin 519
Chandler 505
Jacksonville 372
Nanjing 269
Ann Arbor 152
Beijing 145
Nanchang 130
Ashburn 119
Wilmington 104
Helsinki 91
Lawrence 85
Medford 85
Princeton 85
Shenyang 74
Hebei 70
Changsha 68
New York 67
Jiaxing 61
Boardman 59
Hangzhou 59
Tianjin 58
Shanghai 39
Woodbridge 39
Milan 38
Brussels 27
Verona 25
Norwalk 15
Dearborn 14
Falls Church 14
Pavia 12
Auburn Hills 11
Des Moines 9
Fairfield 9
Tappahannock 9
Jinan 8
Piscataway 8
Kunming 7
Los Angeles 7
Seattle 7
Taizhou 7
Toronto 7
Ningbo 6
Kiel 5
Brno 4
Sacramento 4
San Genesio ed Uniti 4
Zhengzhou 4
Andover 3
Birmingham 3
Fuzhou 3
Groningen 3
Munich 3
Zanjan 3
Changchun 2
Chisinau 2
Costa Mesa 2
Haikou 2
Houston 2
Islamabad 2
Leawood 2
London 2
Monmouth Junction 2
Paderno Dugnano 2
Vienna 2
Amman 1
Andrushivka 1
Baghdad 1
Bengaluru 1
Buenos Aires 1
Cambridge 1
Charlottetown 1
Chorley 1
Delhi 1
Faenza 1
Falkenstein 1
Focsani 1
Fontana 1
Guangzhou 1
Hefei 1
Hyderabad 1
Madrid 1
Melbourne 1
Mumbai 1
Muskego 1
Natchez 1
New Westminster 1
Newbury Park 1
Nürnberg 1
Orange 1
Pedrengo 1
Phoenix 1
Pune 1
Qingdao 1
Raleigh 1
Redmond 1
Reghin 1
Riyadh 1
Rockville 1
San Francisco 1
San Giuliano Milanese 1
Totale 3.592
Nome #
The prion-like doppel protein is soluble in astrocytic tumor 87
Divergent biding sites in pyruvate kinase I and II from Escherichia coli. 83
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis 83
Expanding targets for a metabolic therapy of cancer: L-asparaginase 83
Letter to the editor regarding Shibayama et al.: Biochemical and pathophysiological characterization of Helicobacter pylori asparaginase. 80
Primary structure of three peptides at the catalytic and allosteric sites of the fructose 1,6-bisphosphate-activated pyruvate kinase from Escherichia coli 79
Phosphoglycerate Kinase Deficiency: Characterization of the Wild-Type Enzyme and Three Pathological Variants Generated from C.140T>a, C.491A>T and C.959G>a Mutations 78
Fructose 1,6-biphosphate-activated pyruvate kinase from Escherichia coli: ligands promoted conformational changes 78
Molecular and cellular insights into the aberrant expression of the prion protein-like gene doppel in astrocytic tumors 78
Influence of fibronectine on the fibrillogenesis of type I and type III collagen 77
Generation of Mutants of Helicobacter pylori L-Asparaginase 76
The prion protein-like gene Doppel is aberrantly expressed in astrocytic tumors 75
Two forms of pyruvate kinase in Escherichia coli. A comparison of chemical and molecular properties 73
Structure and function of human erythrocyte pyruvate kinase. Molecular basis of nonspherocytic hemolytic anemia 72
Pyruvate kinase deficiency: Biochemical characterization of two mutations causing inability of the enzyme to properly bind substrates 70
Mycobacterium tuberculosis Phosphoribosylpyrophosphate Synthetase: Biochemical Features of a Crucial Enzyme for Mycobacterial Cell Wall Biosynthesis. 70
Absence of interaction between doppel and GFAP, Grb2, PrPC proteins in human tumor astrocytic cells 69
Engineering of Helicobacter pylori L-asparaginase: characterization of two functionally distinct groups of mutants 69
Aberrant Doppel Protein Expression in Human Astrocytic Tumors 68
Rapid detection of ornithine transcarbamylase activity by micellar electrokinetic chromatography. 68
Recombinant pyruvate kinase type I from Escherichia coli:overproduction and revised C-terminus of the polypeptide 67
A simple procedure for the purification of neutral salt soluble type I collagene from skin. 66
Erythrocyte Adenylate Kinase Deficiency: First In-Depth Biochemical Characterization of the Y164C Mutant Enzyme Causing Hemolytic Anemia 65
Ectopic expression of the prion-like protein doppel in human astrocytoma cells 65
Purification and molecular properties of the AMP-activated pyruvate kinase from Escherichia coli. 64
Fructose 1,6-biphosphate-activated pyruvate kinase from Escherichia coli. Natures of bonds involved in the allosteric mecchanism. 63
Affinity labelling of the catalytic and allosteric ATP binding sites on pyruvate kinase type I from Escherichia coli. 63
Molecular cloning and characterisation of Helicobacter pylori L-asparaginase 63
A comparative study on liver ornithine carbamoyl transferase from a marine mammal Stenella and a elasmobranch Sphyrna zygaena. 62
Biochemical signatures of doppel (Dpl) protein in human glioblastoma to support prediction in tumor malignancy 62
Crystallization and preliminary X-ray analysis of pyruvate kinase type I from Escherichia coli. 62
AMP- and fructose 1,6-biphosphate-activated pyruvate kinase from Escherichia coli. 61
Helicobacter pylori: from gene to Diagnostic Tool 61
Helicobacter pylori L-asparaginase: from Gene to Diagnostic Tool 61
An essential lysine in the substrate-binding of ornithine carbamoyl transferase 60
SELECTION OF MICROFUNGI WITH HIGH LIPOLYTIC ACTIVITYAND THEIR LIPASE CHARACTERIZATION 60
Inosine monophosphate dehydrogenase activity after mycophenolate mofetil in renal transplant patients receiving different immunosupressive combined therapy and stable after at least three months' administration. 60
Reactivity of the fructose 1,6-biphosphate-activated pyruvate kinase from Escherichia coli with pyridoxal 5’-phosphate 59
Premio Ricercatissimi 2008 59
Biochemistry of Lipolytic Enzymes Secreted by Penicillium solitum and Cladosporium cladosporioides 59
Human erythrocyte pyruvate kinase:characterization of the recombinant enzyme and a mutant form(R510Q))causing nonspherocytic hemolytic anemia. 59
Pyrimidine 5' Nucleotidase Deficiency: Clinical and Molecular Characterization of Two New Italian Patients 59
Crystal structure of Escherichia coli pyruvate kinase type I: molecular basis of the allosteric transition 59
Molecular Characterization of Three New Mutant Enzymes of Pyrimidine 5-Nucleotidase Causing Hereditary Hemolytic Anemia. 57
Expanding Targets for a Metabolic Therapy of Cancer: L- Asparaginase 56
Clinical Severity of PGK1 Deficiency Due To a Novel p.E120K Substitution Is Exacerbated by Co-inheritance of a Subclinical Translocation t(3;14)(q26.33;q12), Disrupting NUBPL Gene. 56
Molecular and functional characterization of a lethal variant of pyruvate kinase deficiency 55
The allosteric regulation of pyruvate kinase 55
Cell-cycle inhibition by Helicobacter pylori L-asparaginase. 55
Micellar electrokinetic chromatography as a complementary method to sodium dodecyl sulfate-polyacrylamide gel electrophoresis for studying limited proteolysis of proteins. 55
Molecular basis of pyrimidine 5'-nucleotidase deficiency caused by 3 newly identified missense mutations (c.187T>C, c.469G>C and c.740T>C) and a tabulation of known mutations 55
Bacterial pyruvate kinases have a shorter N-terminal domain 55
Characterization of a pyrimidine 5'-nucleotidase mutant form (G214R) causing hereditary hemolytic anemia. 55
Functional and structural characterization of ovine ornithine transcarbamoylase 54
PYRUVATE KINASE DEFICIENCY: MOLECULAR AND FUNCTIONAL CHARACTERISATION OF A LETHAL VARIANT 54
Structural and Energetic Basis of Protein Kinetic Destabilization in Human Phosphoglycerate Kinase 1 Deficiency 54
A new mutation of the pgk1 gene detected in an italian patient affected by phosphoglycerate kinase deficiency. 54
The allosteric regulation of pyruvate kinase. 54
Hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency: a biochemical, genetic and clinical overview 53
EXPRESSION AND CHARACTERIZATION OF THE BOVINE PRION DOPPEL 53
Molecular Insights on Pathogenic Effects of MutationsCausing Phosphoglycerate Kinase Deficiency 52
Red cell pyruvate kinase deficiency: molecular and clinical aspects 51
Red cell pyruvate kinase deficiency: 17 new mutations of the PK-LR gene 51
Nuclear mRNA retention and aberrant doppel protein expression in human astrocytic tumor cells 51
Pyrimidine 5'-nucleotidase activities detected in real samples by means of micellar electrokinetic chromatography. 50
Pyruvate kinase deficiency : The genotype-phenotype association 50
Hereditary pyrimidine 5'-nucleotidase deficiency: from genetics to clinical manifestations. 49
L-ASPARAGINASE FROM HELICOBACTER PYLORI 49
Investigating the Molecular Bases of the Phosphoglycerate Kinase Deficiency: Characterization ofG158V, R206P, V266M and D285V Pathological Variants. 49
Aeroplane shaped crystal of a mutant ofHelicobacter pylori L-asparaginase. 49
Two new mutations of the P5'N-1 gene found in Italian patients with hereditary hemolytic anemia: the molecular basis of the red cell enzyme disorder. 48
Protein Stability, Folding and Misfolding in Human PGK1 Deficiency 47
Molecular Basis of Hemolytic Anemia: First Biochemical Characterization of Wild-Type and N190S Mutant Human Erythrocyte Pyrimidine 5'-Nucleotidase. 47
Functional Analysis of Two Mutants of Pyrimidine 5’ Nucleotidase Causing Nonspherocytic Hemolytic Anemia 46
Erythrocyte adenylate kinase deficiency: characterization of recombinant mutant forms and relationship with nonspherocytic hemolytic anemia 46
Functional analysis of pyrimidine 5'-nucleotidase mutants causing nonspherocytic hemolytic anemia 43
Monitoring Inosine monophosphate dehydrogenase (IMPDH) in kidney transplant recipients 43
A new variant of phosphoglycerate kinase deficiency (p.I371K) with multiple tissue involvement: molecular and functional characterization. 42
Molecular Cloning and Characterisation of Helicobacter Pylori L-Asparaginase: A Cytotoxic Factor with Potential Biomedical Applications 37
Helicobacter pylori L-asparaginase: A promising chemotherapeutic agent 37
Tackling Critical Catalytic Residues in Helicobacter pylori L-Asparaginase 33
PHOSPHOGLYCERATE KINASE DEFICIENCY: FUNCTIONAL PROPERTIES OF THE L89P, K191DEL, C316R AND A354P PATHOLOGICAL VARIANTS 31
The interplay between protein stability and folding co-operativity in loss-of-function genetic disease: The case of human PGK1 deficiency. 28
Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy 28
Protein stability, folding and misfolding in human PGK1 deficiency 11
Totale 4.933
Categoria #
all - tutte 15.514
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.514


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201910 0 0 0 0 0 0 0 0 0 0 3 7
2019/20201.244 334 462 7 63 4 65 18 79 16 109 81 6
2020/2021605 78 46 25 63 4 79 8 87 19 91 86 19
2021/2022450 6 7 9 6 26 17 15 32 32 20 51 229
2022/20231.411 124 122 9 128 157 155 1 64 594 8 32 17
2023/2024501 121 70 6 43 50 141 7 32 0 12 19 0
Totale 4.933